Asia Pacific In Vitro Fertilization Market Size & Outlook
Global Market
Related Markets
Asia Pacific in vitro fertilization market highlights
- The Asia Pacific in vitro fertilization market generated a revenue of USD 10,230.0 million in 2025.
- The market is expected to grow at a CAGR of 6.25% from 2026 to 2033.
- In terms of segment, frozen nondonor was the largest revenue generating procedure type in 2025.
- Fresh Donor is the most lucrative procedure type segment registering the fastest growth during the forecast period.
- Country-wise, Thailand is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 10,230.0 million |
| Market revenue in 2033 | USD 16,818.0 million |
| Growth rate | 6.25% (CAGR from 2026 to 2033) |
| Largest segment | Frozen nondonor |
| Fastest growing segment | Fresh Donor |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
| Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 35.6% of the global in vitro fertilization market in 2025.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 16,818.0 million by 2033.
The demand for IVF treatments is expected to increase owing to the growth in fertility tourism, increase in the number of international companies trying to penetrate economically developing countries, and change in the regulatory landscape in APAC. The Asia Pacific Initiative on Reproduction (ASPIRE) is a task force of clinicians & scientists engaged in the management of fertility & ART.
This promotes awareness regarding infertility & ART and enhances infertility-related services in the region. According to OECD, in 2022, birth rate in Asia Pacific has fallen to population replacement rate of 2.1 born children per woman. Decrease in birth rate and increase in the geriatric population are among the key factors expected to propel market growth.
This is likely to pose an economic challenge to support aging population. However, it would help cope with the declining birth rate and aid in the replacement of the aging workforce with younger workers. Asian countries such as South Korea, Japan, and Singapore offer partial coverage for ART.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
In Vitro Fertilization Market Scope
In Vitro Fertilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Boston Scientific Corp | View profile | 48,000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | www.bostonscientific.com |
| Vitrolife AB ADR | View profile | 1,116 | Box 9080, Gothenburg, Sweden, 400 92 | www.vitrolife.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| The Cooper Companies Inc | View profile | 15,000 | 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, United States, 94583 | www.coopercos.com |
| Genea Biomedx | View profile | 101-250 | Sydney, New South Wales, Australia, Oceania | www.geneabiomedx.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Cook Medical | View profile | 10001+ | Bloomington, Indiana, United States, North America | www.cookmedical.com |
Asia Pacific In Vitro Fertilization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 52.32% in 2025.
Horizon Databook has segmented the Asia Pacific in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
The demand for IVF treatments is expected to increase owing to the growth in fertility tourism, increase in the number of international companies trying to penetrate economically developing countries, and change in the regulatory landscape in APAC. The Asia Pacific Initiative on Reproduction (ASPIRE) is a task force of clinicians & scientists engaged in the management of fertility & ART.
This promotes awareness regarding infertility & ART and enhances infertility-related services in the region. According to OECD, in 2022, birth rate in Asia Pacific has fallen to population replacement rate of 2.1 born children per woman. Decrease in birth rate and increase in the geriatric population are among the key factors expected to propel market growth.
This is likely to pose an economic challenge to support aging population. However, it would help cope with the declining birth rate and aid in the replacement of the aging workforce with younger workers. Asian countries such as South Korea, Japan, and Singapore offer partial coverage for ART.
- Asia Pacific In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
- Fresh Nondonor
- Frozen Nondonor
- Fresh Donor
- Frozen Donor
- Asia Pacific In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
- Fertility Clinics
- Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
- Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific In Vitro Fertilization Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific In Vitro Fertilization Market, 2021-2033 (US$M)
Asia Pacific in vitro fertilization market statistics, by procedure type, 2021-2033 (US$M)
